Cancer Clinical Trial
Official title:
Multidisciplinary Consultation at the GHM Hospital of Grenoble (France) for the Establishment of an Oral Anti-cancer Drug Therapy : Feasibility, Security, and Evaluation of Patients' and City Health Professionals' Satisfaction.
During the last few years, the medical care of oncohematologic cancers diagnosed patients was
shaken by the arrival of new therapies : targeted therapies. Very efficient, these therapies
use the oral pathway in most cases, and are taken at home. These treatments show plenty of
drug interactions and side effects aren't rare and require, in their own, a rigorous follow
up in order to reduce their occurrence, intensity and their impact on patients' quality of
life. A bad management of the treatment could lead to an inacceptable toxicity, or to its
premature interruption.
With all the new administration and follow up strains in mind, we want to elaborate the
medical pathway structure for these patients by reinforcing the nurse coordination and by
integrating another healthcare professional : the hospital pharmacist, which is a
professional especially implicated in the drug delivery, the control of drug interactions and
medical advices relative to the given drug.
Private healthcare professionals (referring physicians, pharmacists, private nurses),
unsufficiently trained and informed about these new treatments and their side effects, are
asking for further information concerning the drugs prescribed to their patients, and are
willing to keep open a communication line for the home follow up.
These patients, who are autonomously taking their medication, are in need to be informed and
supported to insure the good management of the drug, while taking in account their
environment, their knowledge of their cancer and treatment and also of all the issues that
could occur during their therapy, in order to resolve them.
We propose a multidisciplinary medical care taking place at the very beginning of an oral
therapy treatment, in order to ensure the security of the drug administration. Patients and
healthcare professionals will be closely followed during the first two treatment cycles.
After this, side-effects incidence are less frequent and the usual oncohematologic follow up
is sufficient.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
| Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|